Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gypenoside XLIX loaded nanoparticles targeting therapy for renal fibrosis and its mechanism
Qixia Liu, Xiaohong Chen, Min Kan, et al.
European Journal of Pharmacology (2021) Vol. 910, pp. 174501-174501
Closed Access | Times Cited: 17

Showing 17 citing articles:

Nanosuspensions technology as a master key for nature products drug delivery and In vivo fate
Yingying Ma, Zhufeng Cong, Peng Gao, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 185, pp. 106425-106425
Open Access | Times Cited: 42
Advances in drug delivery-based therapeutic strategies for renal fibrosis treatment
Sida Huang, H. R. Lu, Chen Jin, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 27, pp. 6532-6549
Closed Access | Times Cited: 36
Recent advances in self-targeting natural product-based nanomedicines
Haifan Liu, Xingyue Jin, Suyi Liu, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 3
The development of nanocarriers for natural products
Liying Huang, Shicui Luo, Sen Tong, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 3
Closed Access | Times Cited: 6
Renal drug delivery

Drug delivery (2025), pp. 263-281
Open Access
A quantitative review of nanotechnology‐based therapeutics for kidney diseases
Hui‐Teng Cheng, Yen‐Nhi Ngoc Ta, Tiffaney Hsia, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 2
Closed Access | Times Cited: 3
Targeted drug delivery strategy: a bridge to the therapy of diabetic kidney disease
Xian Chen, Wenni Dai, Hao Li, et al.
Drug Delivery (2022) Vol. 30, Iss. 1
Open Access | Times Cited: 15
Gypenosides Attenuate Pulmonary Fibrosis by Inhibiting the AKT/mTOR/c-Myc Pathway
Suqing Liu, Qingqing Yang, Binbin Dong, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 14
Gypenosides suppress fibrosis of the renal NRK-49F cells by targeting miR-378a-5p through the PI3K/AKT signaling pathway
Lan Zhang, Xiting Wang, Shuangshuang He, et al.
Journal of Ethnopharmacology (2023) Vol. 311, pp. 116466-116466
Closed Access | Times Cited: 6
Gypenoside XLIX attenuates sepsis-induced splenic injury through inhibiting inflammation and oxidative stress
Baoshi Xu, Rongrong Yang, Jingchao Qiang, et al.
International Immunopharmacology (2023) Vol. 127, pp. 111420-111420
Closed Access | Times Cited: 6
Renal Proximal Tubular Cells: A New Site for Targeted Delivery Therapy of Diabetic Kidney Disease
Hao Li, Wenni Dai, Zhiwen Liu, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1494-1494
Open Access | Times Cited: 9
Biopolymer-Based Nanosystems: Potential Novel Carriers for Kidney Drug Delivery
Hao Li, Wenni Dai, Li Xiao, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2150-2150
Open Access | Times Cited: 5
Enzymatic Biotransformation of Gypenoside XLIX into Gylongiposide I and Their Antiviral Roles against Enterovirus 71 In Vitro
Huanxi Zhao, Wenbo Jiao, Yang Xiu, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4094-4094
Open Access | Times Cited: 8
Nanocarrier-Based Localized and Effective Treatment of Renal Disorders: Currently Employed Targeting Strategies
Syed Saad Ullah, Samiullah Burki, Abu Bakar Munir, et al.
Nanomedicine (2024) Vol. 19, Iss. 4, pp. 345-361
Closed Access | Times Cited: 1
Nanomedicine embraces the treatment and prevention of acute kidney injury to chronic kidney disease transition: evidence, challenges, and opportunities
Jia Li, Jiayu Duan, Chaoyang Hua, et al.
Burns & Trauma (2024) Vol. 12
Open Access | Times Cited: 1
Insulin-like growth factor-binding protein7 exacerbates inflammatory response and lipid metabolism imbalance in alcohol-associated liver disease
Min Kan, Ruonan Wang, Le Chen, et al.
Free Radical Biology and Medicine (2024)
Closed Access
Identification and Validation of Genes Exhibiting Dynamic Alterations in Response to Bleomycin-Induced Pulmonary Fibrosis
Deng‐Yuan Li, Jun Wang, Jie Zeng, et al.
Molecular Biotechnology (2023) Vol. 66, Iss. 11, pp. 3323-3335
Closed Access | Times Cited: 1
Page 1

Scroll to top